Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antimalarial transmission-blocking vaccines

R E Sinden1

  • 1Department of Biology, Imperial College of Science, Technology and Medicine, London, UK.

Science Progress
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the Parasite to Suppress Malaria Transmission.

Advances in parasitology·2017
Same author

Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax.

Vaccine·2016
Same author

Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.

Scientific reports·2015
Same author

The cell biology of malaria infection of mosquito: advances and opportunities.

Cellular microbiology·2015
Same author

The Plasmodium berghei sexual stage antigen PSOP12 induces anti-malarial transmission blocking immunity both in vivo and in vitro.

Vaccine·2014
Same author

Lead clinical and preclinical antimalarial drugs can significantly reduce sporozoite transmission to vertebrate populations.

Antimicrobial agents and chemotherapy·2014
Same journal

Stroke risk associated with the interaction between composite dietary antioxidant index and heavy metals: A cross-sectional explainable machine learning study using NHANES data.

Science progress·2026
Same journal

Neuroimaging in schizophrenia: From group-average abnormalities to individualised circuit models.

Science progress·2026
Same journal

Clinical and mechanistic effects of GLP-1 receptor agonists in hidradenitis suppurativa and comorbidities.

Science progress·2026
Same journal

Association between serum albumin-to-globulin ratio and diabetic retinopathy: A cross-sectional study based on the 2001-2020 NHANES database.

Science progress·2026
Same journal

Prognostic value of the triglyceride-glucose index combined with glycemic variability for all-cause mortality in patients with sepsis: A retrospective cohort study.

Science progress·2026
Same journal

Asynchronous federated learning with partial weights aggregation for energy consumption forecasting.

Science progress·2026
See all related articles

Malaria control is advancing with new transmission-blocking vaccines aimed at preventing parasite spread from humans to mosquitoes. These vaccines show promise in reducing malaria transmission, with candidates entering human trials.

Area of Science:

  • Medical Entomology
  • Parasitology
  • Vaccinology

Background:

  • Malaria remains a significant global health burden, particularly in tropical regions, causing millions of deaths annually.
  • Existing control methods like vector control and chemotherapy have limitations in fully eradicating the disease.

Purpose of the Study:

  • To review the development and potential of transmission-blocking vaccines (TBVs) for malaria control.
  • To discuss candidate antigens, ongoing research questions, and novel strategies for malaria transmission interruption.

Main Methods:

  • Review of current literature on malaria vector control and chemotherapy.
  • Analysis of laboratory studies and early-stage human trials for transmission-blocking vaccines.
  • Exploration of emerging and unexpected approaches in malaria control.

Related Experiment Videos

Main Results:

  • Transmission-blocking vaccines represent a promising new tool to combat malaria by targeting parasite transmission.
  • Several candidate antigens are under development, with at least one progressing to human trials.
  • Laboratory data suggest significant potential for reducing malaria transmission.

Conclusions:

  • Transmission-blocking vaccines offer a novel strategy to complement existing malaria control measures.
  • Further research is needed to address remaining questions and optimize vaccine efficacy.
  • Innovative approaches are crucial for developing effective tools against this pathogen.